DynaGen Inc. announced that it has raised $2.35 million fromthe exercise of 98 percent of the 1.6 million warrants issuedin the company's August 1990 initial public offering. Thewarrants, which expired on July 19, entitled holders topurchase one share of common stock at $1.50 per share.Cambridge, Mass.-based DynaGen develops diagnostic andtherapeutic products and drug-delivery systems. The company'sstock (NASDAQ:DYGN) closed at $6.63, down 9 cents, onThursday.

(c) 1997 American Health Consultants. All rights reserved.